Spravato vs. Ketamine-Assisted Psychotherapy: What’s the Difference?

If you’ve been researching options for treatment-resistant depression in Michigan, you’ve probably come across two therapies that sound similar but work differently: Spravato and Ketamine-Assisted Psychotherapy (KAP). Both are offered here at Relationship Academy MI in collaboration with Journey Clinical’s medical team, and both pair medication with psychotherapy—but the medication, setting, and FDA status are different. Here’s how to tell them apart.

---

What Spravato Is

Spravato (esketamine) is an FDA-approved nasal spray specifically indicated for adults with treatment-resistant depression—depression that hasn’t responded to standard oral antidepressants. It’s administered in a certified clinical setting under direct medical supervision, typically a few times a week during the initial induction phase.

---

What KAP Is

Ketamine-Assisted Psychotherapy uses a sublingual ketamine lozenge, prescribed and monitored by Journey Clinical’s medical team, but self-administered at home while your therapist is present with you via telehealth. It’s used off-label to support a broader range of concerns — depression, anxiety, trauma, and relationship-related struggles.

---

Key Differences at a Glance

• FDA status: Spravato is FDA-approved for treatment-resistant depression specifically. Ketamine used in KAP is prescribed off-label, a common and legal practice for medications with an established safety profile.
• Setting: Spravato dosing happens in a supervised clinical site. KAP dosing happens at home, with your therapist present remotely.
• Who it’s typically used for: Spravato is intended for adults with a diagnosis of treatment-resistant depression. KAP is often used more broadly for mood, anxiety, trauma, and relational work.
• The therapy piece stays the same: Both models pair the medical treatment with dedicated preparation and integration sessions with your therapist — the medicine is the catalyst, but the therapeutic work is what helps translate the experience into lasting change.

---

How to Decide

There’s no single “better” option — the right fit depends on your diagnosis, your comfort with an in-clinic setting vs. home setting, and what your insurance covers. A good starting point:

• If you’ve been formally diagnosed with treatment-resistant depression and want an FDA-approved option, Spravato may be worth discussing with Journey Clinical’s team.
• If you’re looking for a more flexible framework that can address anxiety, trauma, or relationship patterns alongside mood symptoms, KAP may be a better starting conversation.

Either way, the decision about eligibility and medical appropriateness is made by Journey Clinical’s medical team, not by this website — this article is educational, not medical advice.

---

FAQ